Diversity of Abeta deposits in the aged brain: a window on molecular heterogeneity? - PubMed (original) (raw)
Affiliations
- PMID: 18273496
Free article
Review
Diversity of Abeta deposits in the aged brain: a window on molecular heterogeneity?
L C Walker et al. Rom J Morphol Embryol. 2008.
Free article
Abstract
The Abeta peptide forms a morphologically heterogeneous assortment of aggregates in the brains of patients with Alzheimer's disease. The reasons for the diversity of the histopathologically identified lesions (Abeta-plaques and cerebral beta-amyloid angiopathy) are uncertain. However, there is growing evidence for the existence of higher order structural heterogeneity in protein molecules with the same amino acid sequence and differential involvement in disease. Focused analysis of plaque morphotypes could yield novel insights into the organization and function of putative protein variants in the diseased brain. In addition to classical amyloid-selective dyes, new techniques are emerging to undertake such analyses, including selective, small molecule binding agents, specific antibodies, and conformationally sensitive optical probes. By illuminating the relationships between specific lesions and their molecular components, these agents can help to clarify the complex pathology of Alzheimer's disease.
Similar articles
- Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display.
Wiesehan K, Buder K, Linke RP, Patt S, Stoldt M, Unger E, Schmitt B, Bucci E, Willbold D. Wiesehan K, et al. Chembiochem. 2003 Aug 4;4(8):748-53. doi: 10.1002/cbic.200300631. Chembiochem. 2003. PMID: 12898626 - Amyloid-beta aggregation.
Finder VH, Glockshuber R. Finder VH, et al. Neurodegener Dis. 2007;4(1):13-27. doi: 10.1159/000100355. Neurodegener Dis. 2007. PMID: 17429215 Review. - Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains.
Welander H, Frånberg J, Graff C, Sundström E, Winblad B, Tjernberg LO. Welander H, et al. J Neurochem. 2009 Jul;110(2):697-706. doi: 10.1111/j.1471-4159.2009.06170.x. Epub 2009 May 15. J Neurochem. 2009. PMID: 19457079 - Intracellular amyloid-beta in Alzheimer's disease.
LaFerla FM, Green KN, Oddo S. LaFerla FM, et al. Nat Rev Neurosci. 2007 Jul;8(7):499-509. doi: 10.1038/nrn2168. Nat Rev Neurosci. 2007. PMID: 17551515 Review. - Dense-core and diffuse Abeta plaques in TgCRND8 mice studied with synchrotron FTIR microspectroscopy.
Rak M, Del Bigio MR, Mai S, Westaway D, Gough K. Rak M, et al. Biopolymers. 2007 Nov;87(4):207-17. doi: 10.1002/bip.20820. Biopolymers. 2007. PMID: 17680701
Cited by
- The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.
Hunter S, Arendt T, Brayne C. Hunter S, et al. Mol Neurobiol. 2013 Dec;48(3):556-70. doi: 10.1007/s12035-013-8445-3. Epub 2013 Apr 3. Mol Neurobiol. 2013. PMID: 23546742 Review. - Nonhuman primate models of Alzheimer-like cerebral proteopathy.
Heuer E, Rosen RF, Cintron A, Walker LC. Heuer E, et al. Curr Pharm Des. 2012;18(8):1159-69. doi: 10.2174/138161212799315885. Curr Pharm Des. 2012. PMID: 22288403 Free PMC article. Review. - Phosphorylation of amyloid beta (Aβ) peptides - a trigger for formation of toxic aggregates in Alzheimer's disease.
Kumar S, Walter J. Kumar S, et al. Aging (Albany NY). 2011 Aug;3(8):803-12. doi: 10.18632/aging.100362. Aging (Albany NY). 2011. PMID: 21869458 Free PMC article. - Clinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's disease.
Pahnke J, Wolkenhauer O, Krohn M, Walker LC. Pahnke J, et al. Curr Alzheimer Res. 2008 Aug;5(4):396-405. doi: 10.2174/156720508785132262. Curr Alzheimer Res. 2008. PMID: 18690837 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources